98 related articles for article (PubMed ID: 9618321)
21. National Institute of Environmental Health Sciences (NIEHS); the Murine Local Lymph Node Assay: a Test Method for Assessing the Allergic Contact Dermatitis Potential of Chemicals/Compounds, report now available. Public Health Service.
Fed Regist; 1999 Mar; 64(55):14006-7. PubMed ID: 10558409
[TBL] [Abstract][Full Text] [Related]
22. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
Box RJ; Spielmann H
Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
[TBL] [Abstract][Full Text] [Related]
23. [Diagnostic kits in parasitology: which controls?].
Rossi P
Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
[TBL] [Abstract][Full Text] [Related]
24. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
25. How to anticipate the assessment of the public health benefit of new medicines?
Massol J; Puech A; Boissel JP;
Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
[TBL] [Abstract][Full Text] [Related]
26. The United States Department of Energy's Regional Carbon Sequestration Partnerships Program Validation Phase.
Litynski JT; Plasynski S; McIlvried HG; Mahoney C; Srivastava RD
Environ Int; 2008 Jan; 34(1):127-38. PubMed ID: 17950875
[TBL] [Abstract][Full Text] [Related]
27. ICCVAM evaluation of the murine local lymph node assay. Conclusions and recommendations of an independent scientific peer review panel.
Dean JH; Twerdok LE; Tice RR; Sailstad DM; Hattan DG; Stokes WS
Regul Toxicol Pharmacol; 2001 Dec; 34(3):258-73. PubMed ID: 11754530
[TBL] [Abstract][Full Text] [Related]
28. ECVAM and the Promotion of International Co-operation in the Development, Validation and Acceptance of Replacement Alternative Test Methods.
Balls M
ALTEX; 1999; 16(4):280-282. PubMed ID: 11107329
[TBL] [Abstract][Full Text] [Related]
29. Alternatives to animal experimentation: the regulatory background.
Garthoff B
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):388-92. PubMed ID: 15982684
[TBL] [Abstract][Full Text] [Related]
30. Replacement of in vivo acute oral toxicity studies by in vitro cytotoxicity methods: opportunities, limits and regulatory status.
Ukelis U; Kramer PJ; Olejniczak K; Mueller SO
Regul Toxicol Pharmacol; 2008 Jun; 51(1):108-18. PubMed ID: 18362045
[TBL] [Abstract][Full Text] [Related]
31. Alternative tests make the grade.
Booker S
Environ Health Perspect; 2000 Mar; 108(3):A118-9. PubMed ID: 10706538
[TBL] [Abstract][Full Text] [Related]
32. Applications of emerging technologies in toxicology and safety assessment.
Reynolds VL
Int J Toxicol; 2005; 24(3):135-7. PubMed ID: 16040564
[TBL] [Abstract][Full Text] [Related]
33. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
34. Concept of REACH and impact on evaluation of chemicals.
Foth H; Hayes A
Hum Exp Toxicol; 2008 Jan; 27(1):5-21. PubMed ID: 18480145
[TBL] [Abstract][Full Text] [Related]
35. Validation of tests methods in the quality control of biologicals.
Hendriksen CF
Dev Biol Stand; 1999; 101():217-21. PubMed ID: 10566796
[TBL] [Abstract][Full Text] [Related]
36. Six Sigma: not for the faint of heart.
Benedetto AR
Radiol Manage; 2003; 25(2):40-53. PubMed ID: 12800564
[TBL] [Abstract][Full Text] [Related]
37. Ensuring quality of in vitro alternative test methods: issues and answers.
Gupta K; Rispin A; Stitzel K; Coecke S; Harbell J
Regul Toxicol Pharmacol; 2005 Dec; 43(3):219-24. PubMed ID: 16099570
[TBL] [Abstract][Full Text] [Related]
38. Current ecotoxicity testing needs among selected U.S. federal agencies.
Ceger P; Garcia-Reyero Vinas N; Allen D; Arnold E; Bloom R; Brennan JC; Clarke C; Eisenreich K; Fay K; Hamm J; Henry PFP; Horak K; Hunter W; Judkins D; Klein P; Kleinstreuer N; Koehrn K; LaLone CA; Laurenson JP; Leet JK; Lowit A; Lynn SG; Norberg-King T; Perkins EJ; Petersen EJ; Rattner BA; Sprankle CS; Steeger T; Warren JE; Winfield S; Odenkirchen E
Regul Toxicol Pharmacol; 2022 Aug; 133():105195. PubMed ID: 35660046
[TBL] [Abstract][Full Text] [Related]
39. Participation in programs designed to improve employment outcomes for persons with psychiatric disabilities: evidence from the New York WORKS demonstration project.
Ruiz-Quintanilla SA; Weathers RR; Melburg V; Campbell K; Madi N
Soc Secur Bull; 2005-2006; 66(2):49-79. PubMed ID: 16878427
[TBL] [Abstract][Full Text] [Related]
40. [Efficiency versus quality in the NHS, in Portugal: methodologies for evaluation].
Giraldes Mdo R
Acta Med Port; 2008; 21(5):397-410. PubMed ID: 19187682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
